Early and locally advanced breast cancer. Implementing NICE guidance. 2009. NICE clinical guideline 80. What this presentation covers. Background Scope Key priorities for implementation Savings Discussion Find out more . Background. Most common cancer in women in England and Wales
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Implementing NICE guidance
NICE clinical guideline 80
Key priorities for implementation
Find out more
The guideline supports the:
It refers to NICE cancer service guidance:
The areas identified as key priorities for implementation are:
• Preoperative assessment of the breast
• Staging of the axilla
• Surgery to the axilla
• Breast reconstruction
• Adjuvant therapy planning
• Aromatase inhibitors
• Assessment of bone loss
• Primary systemic therapy
• Follow-up imaging
• Clinical follow-up
Offer magnetic resonance imaging (MRI) of the breast to patients with invasive breast cancer:
• Postmenopausal women with ER-positive early invasive breast cancer who are not considered to be at low risk should be offered an aromatase inhibitor, either anastrozole or letrozole, as their initial adjuvant therapy. Offer tamoxifen if an aromatase inhibitor is contraindicated ornot tolerated
Patients with early invasive breast cancer should have a baseline dual energy X-ray absorptiometry (DEXA) scan to assess bone mineral density if they:
Patients should have an agreed , written care plan recorded by a named healthcare professional, to include:
Send a copy to the GP and give a copy to the patient.
How do we ensure that patients are enabled and supported in making decisions about
How do we recognise when a patient is in need of extra support (for example, emotional, psychological, social, cultural)?
What protocols for support do we have in place when a patient’s choice of reconstructive surgery is not available here?
Visit www.nice.org.uk/CG080 for: